{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:46:55Z","timestamp":1791830815731,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL166246"],"award-info":[{"award-number":["1R01HL166246"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62789-5","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:19:29Z","timestamp":1756747169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-341X","authenticated-orcid":false,"given":"Amelia K.","family":"Haj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-9782","authenticated-orcid":false,"given":"Sean J.","family":"Jurgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-1138","authenticated-orcid":false,"given":"Harish","family":"Eswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Chen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6743-5390","authenticated-orcid":false,"given":"Alfonso","family":"Rodriguez Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-3979","authenticated-orcid":false,"given":"Sharjeel","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-0360","authenticated-orcid":false,"given":"Satoshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7700","authenticated-orcid":false,"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-8861","authenticated-orcid":false,"given":"Wolfgang","family":"Bergmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3880-5361","authenticated-orcid":false,"given":"Alex","family":"Burgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-5149","authenticated-orcid":false,"given":"Joel T.","family":"R\u00e4m\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0349-5714","authenticated-orcid":false,"given":"Pavan K.","family":"Bendapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"62789_CR1","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel, T. L. et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 4, 4693\u20134738 (2020).","journal-title":"Blood Adv."},{"key":"62789_CR2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli, G. et al. Apixaban for the treatment of venous thromboembolism associated with cancer.  N. Engl. J. Med. 382, 1599\u20131607 (2020).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation.  N. Engl. J. Med. 365, 981\u2013992 (2011).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","volume":"364","author":"SJ Connolly","year":"2011","unstructured":"Connolly, S. J. et al. Apixaban in patients with atrial fibrillation.  N. Engl. J. Med. 364, 806\u2013817 (2011).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"E-P Investigators","year":"2012","unstructured":"Investigators, E.-P. et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.  N. Engl. J. Med. 366, 1287\u20131297 (2012).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.  N. Engl. J. Med. 365, 883\u2013891 (2011).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR7","doi-asserted-by":"publisher","first-page":"e234059","DOI":"10.1001\/jamanetworkopen.2023.4059","volume":"6","author":"GS Iyer","year":"2023","unstructured":"Iyer, G. S., Tesfaye, H., Khan, N. F., Zakoul, H. & Bykov, K. Trends in the Use of Oral Anticoagulants for adults with venous thromboembolism in the US, 2010\u20132020. JAMA Netw. Open 6, e234059 (2023).","journal-title":"JAMA Netw. Open"},{"key":"62789_CR8","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1182\/bloodadvances.2021005966","volume":"5","author":"BJ Carney","year":"2021","unstructured":"Carney, B. J. et al. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. Blood Adv. 5, 5546\u20135553 (2021).","journal-title":"Blood Adv."},{"key":"62789_CR9","doi-asserted-by":"publisher","first-page":"e12500","DOI":"10.1002\/rth2.12500","volume":"5","author":"NE Brunton","year":"2021","unstructured":"Brunton, N. E. et al. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes. Res Pract. Thromb. Haemost. 5, e12500 (2021).","journal-title":"Res Pract. Thromb. Haemost."},{"key":"62789_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/MOH.0000000000000603","volume":"27","author":"P Srivastava","year":"2020","unstructured":"Srivastava, P. & Gailani, D. The rebirth of the contact pathway: a new therapeutic target. Curr. Opin. Hematol. 27, 311\u2013319 (2020).","journal-title":"Curr. Opin. Hematol."},{"key":"62789_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","volume":"37","author":"KF Nickel","year":"2017","unstructured":"Nickel, K. F., Long, A. T., Fuchs, T. A., Butler, L. M. & Renne, T. Factor XII as a therapeutic target in thromboembolic and inflammatory diseases. Arterioscler. Thrombosis. Vasc. Biol. 37, 13\u201320 (2017).","journal-title":"Arterioscler. Thrombosis. Vasc. Biol."},{"key":"62789_CR12","doi-asserted-by":"publisher","first-page":"112753","DOI":"10.1016\/j.ejmech.2020.112753","volume":"208","author":"C Davoine","year":"2020","unstructured":"Davoine, C., Bouckaert, C., Fillet, M. & Pochet, L. Factor XII\/XIIa inhibitors: tTheir discovery, development, and potential indications. Eur. J. Med. Chem. 208, 112753 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"62789_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1055\/s-0037-1603937","volume":"44","author":"B Tillman","year":"2018","unstructured":"Tillman, B. & Gailani, D. Inhibition of factors XI and XII for prevention of thrombosis induced by artificial surfaces. Semin. Thrombosis Hemost. 44, 60\u201369 (2018).","journal-title":"Semin. Thrombosis Hemost."},{"key":"62789_CR14","unstructured":"Loscalzo, J. Thrombosis and Hemorrhage, (Lippincott Williams and Wilkins, 2003)."},{"key":"62789_CR15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1055\/s-0037-1614368","volume":"82","author":"S Zeerleder","year":"1999","unstructured":"Zeerleder, S. et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency-a study on 73 subjects from 14 Swiss families. Thromb. Haemost. 82, 1240\u20131246 (1999).","journal-title":"Thromb. Haemost."},{"key":"62789_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/107602960501100313","volume":"11","author":"A Girolami","year":"2005","unstructured":"Girolami, A. et al. Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotes. Clin. Appl. Thromb. Hemost. 11, 335\u2013338 (2005).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"62789_CR17","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","volume":"120","author":"T Renn\u00e9","year":"2012","unstructured":"Renn\u00e9, T., Schmaier, A. H., Nickel, K. F., Blomb\u00e4ck, M. & Maas, C. In vivo roles of factor XII. Blood 120, 4296\u20134303 (2012).","journal-title":"Blood"},{"key":"62789_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","volume":"125","author":"E Stavrou","year":"2010","unstructured":"Stavrou, E. & Schmaier, A. H. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thrombosis Res. 125, 210\u2013215 (2010).","journal-title":"Thrombosis Res."},{"key":"62789_CR19","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/jth.14964","volume":"18","author":"SA Chaudhry","year":"2020","unstructured":"Chaudhry, S. A. et al. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo. J. Thromb. Haemost. 18, 2318\u20132328 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"62789_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renne","year":"2005","unstructured":"Renne, T. et al. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202, 271\u2013281 (2005).","journal-title":"J. Exp. Med."},{"key":"62789_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1084\/jem.20052458","volume":"203","author":"C Kleinschnitz","year":"2006","unstructured":"Kleinschnitz, C. et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203, 513\u2013518 (2006).","journal-title":"J. Exp. Med."},{"key":"62789_CR22","doi-asserted-by":"publisher","first-page":"222ra217","DOI":"10.1126\/scitranslmed.3006804","volume":"6","author":"M Larsson","year":"2014","unstructured":"Larsson, M. et al. A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci. Transl. Med. 6, 222ra217 (2014).","journal-title":"Sci. Transl. Med."},{"key":"62789_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","volume":"123","author":"A Matafonov","year":"2014","unstructured":"Matafonov, A. et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood 123, 1739\u20131746 (2014).","journal-title":"Blood"},{"key":"62789_CR24","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1111\/jth.15037","volume":"18","author":"SP Grover","year":"2020","unstructured":"Grover, S. P., Olson, T. M., Cooley, B. C. & Mackman, N. Model-dependent contributions of FXII and FXI to venous thrombosis in mice. J. Thromb. Haemost. 18, 2899\u20132909 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"62789_CR25","doi-asserted-by":"crossref","unstructured":"Key, N. S. Epidemiologic and clinical data linking factors XI and XII to thrombosis. Hematol. Am. Soc.Hematol. Educ. Prog. 2014, 66\u201370 (2014).","DOI":"10.1182\/asheducation-2014.1.66"},{"key":"62789_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2141.1994.tb04937.x","volume":"87","author":"T Koster","year":"1994","unstructured":"Koster, T., Rosendaal, F. R., Briet, E. & Vandenbroucke, J. P. John Hageman\u2019s factor and deep-vein thrombosis: Leiden thrombophilia Study. Br. J. Haematol. 87, 422\u2013424 (1994).","journal-title":"Br. J. Haematol."},{"key":"62789_CR27","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","volume":"114","author":"M Cushman","year":"2009","unstructured":"Cushman, M., O\u2019Meara, E. S., Folsom, A. R. & Heckbert, S. R. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 114, 2878\u20132883 (2009).","journal-title":"Blood"},{"key":"62789_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Bruhl","year":"2012","unstructured":"von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"62789_CR29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","volume":"131","author":"C Maas","year":"2018","unstructured":"Maas, C. & Renne, T. Coagulation factor XII in thrombosis and inflammation. Blood 131, 1903\u20131909 (2018).","journal-title":"Blood"},{"key":"62789_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/joim.12430","volume":"278","author":"E Kenne","year":"2015","unstructured":"Kenne, E. et al. Factor XII: a novel target for safe prevention of thrombosis and inflammation. J. Intern. Med. 278, 571\u2013585 (2015).","journal-title":"J. Intern. Med."},{"key":"62789_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","volume":"54","author":"SJ Jurgens","year":"2022","unstructured":"Jurgens, S. J. et al. Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank. Nat. Genet. 54, 240\u2013250 (2022).","journal-title":"Nat. Genet."},{"key":"62789_CR32","doi-asserted-by":"publisher","unstructured":"Thompson, D. J. et al. UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits. medRxiv, https:\/\/doi.org\/10.1101\/2022.06.16.22276246 (2022).","DOI":"10.1101\/2022.06.16.22276246"},{"key":"62789_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"62789_CR34","doi-asserted-by":"crossref","unstructured":"Karlson, E. W., Boutin, N. T., Hoffnagle, A. G. & Allen, N. L. Building the partners HealthCare Biobank at partners personalized medicine: informed consent, return of research results, recruitment lessons and operational considerations. J. Pers. Med. 6, 2 (2016).","DOI":"10.3390\/jpm6010002"},{"key":"62789_CR35","doi-asserted-by":"crossref","unstructured":"Boutin, N. T. et al. The evolution of a large biobank at mass General Brigham. J. Pers. Med. 12, 1323 (2022).","DOI":"10.3390\/jpm12081323"},{"key":"62789_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MOH.0000000000000271","volume":"23","author":"AH Schmaier","year":"2016","unstructured":"Schmaier, A. H. Antithrombotic potential of the contact activation pathway. Curr. Opin. Hematol. 23, 445\u2013452 (2016).","journal-title":"Curr. Opin. Hematol."},{"key":"62789_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOH.0b013e3283497e61","volume":"18","author":"F Muller","year":"2011","unstructured":"Muller, F., Gailani, D. & Renne, T. Factor XI and XII as antithrombotic targets. Curr. Opin. Hematol. 18, 349\u2013355 (2011).","journal-title":"Curr. Opin. Hematol."},{"key":"62789_CR38","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3389\/fimmu.2019.02011","volume":"10","author":"T Renn\u00e9","year":"2019","unstructured":"Renn\u00e9, T. & Stavrou, E. X. Roles of factor XII in innate immunity. Front. Immunol. 10, 2011 (2019).","journal-title":"Front. Immunol."},{"key":"62789_CR39","doi-asserted-by":"crossref","unstructured":"Haj, A. K. et al. Loss of Function in Protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. J. Thromb. Haemost. 23, 171\u2013180 (2024).","DOI":"10.1016\/j.jtha.2024.09.016"},{"key":"62789_CR40","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1111\/jth.15488","volume":"19","author":"S Beck","year":"2021","unstructured":"Beck, S. et al. Generation of a humanized FXII knock-in mouse-A powerful model system to test novel anti-thrombotic agents. J. Thromb. Haemost. 19, 2835\u20132840 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"62789_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-0032-1315758","volume":"38","author":"F Dentali","year":"2012","unstructured":"Dentali, F. et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin. Thromb. Hemost. 38, 535\u2013548 (2012).","journal-title":"Semin. Thromb. Hemost."},{"key":"62789_CR42","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1538-7836.2007.02579.x","volume":"5","author":"T Ohira","year":"2007","unstructured":"Ohira, T. et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J. Thromb. Haemost. 5, 1455\u20131461 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"62789_CR43","doi-asserted-by":"crossref","unstructured":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355, 1295\u20131302 (2000).","DOI":"10.1016\/S0140-6736(00)02110-3"},{"key":"62789_CR44","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"TA Brighton","year":"2012","unstructured":"Brighton, T. A. et al. Low-dose aspirin for preventing recurrent venous thromboembolism.  N. Engl. J. Med. 367, 1979\u20131987 (2012).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR45","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","volume":"366","author":"C Becattini","year":"2012","unstructured":"Becattini, C. et al. Aspirin for preventing the recurrence of venous thromboembolism.  N. Engl. J. Med. 366, 1959\u20131967 (2012).","journal-title":"N. Engl. J. Med."},{"key":"62789_CR46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1126\/science.1652157","volume":"253","author":"D Gailani","year":"1991","unstructured":"Gailani, D. & Broze, G. J. Jr. Factor XI activation in a revised model of blood coagulation. Science 253, 909\u2013912 (1991).","journal-title":"Science"},{"key":"62789_CR47","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s44161-023-00346-3","volume":"2","author":"A Lipov","year":"2023","unstructured":"Lipov, A. et al. Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies. Nat. Cardiovasc. Res. 2, 1078\u20131094 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"62789_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-022-05420-7","volume":"613","author":"HO Heyne","year":"2023","unstructured":"Heyne, H. O. et al. Mono- and biallelic variant effects on disease at biobank scale. Nature 613, 519\u2013525 (2023).","journal-title":"Nature"},{"key":"62789_CR49","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ajhg.2022.05.008","volume":"109","author":"AR Barton","year":"2022","unstructured":"Barton, A. R., Hujoel, M. L. A., Mukamel, R. E., Sherman, M. A. & Loh, P. R. A spectrum of recessiveness among Mendelian disease variants in UK Biobank. Am. J. Hum. Genet 109, 1298\u20131307 (2022).","journal-title":"Am. J. Hum. Genet"},{"key":"62789_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"62789_CR51","unstructured":"UK Biobank \u2013 Final Exome Data Release FAQs\/July. https:\/\/www.ukbiobank.ac.uk\/media\/najcnoaz\/access_064-uk-biobank-exome-release-faq_v11-1_final-002.pdf. accessed 1 March 2022."},{"key":"62789_CR52","unstructured":"U. K. Biobank WES Protocol \/ September 2021. https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/UKB_WES_Protocol.pdf."},{"key":"62789_CR53","doi-asserted-by":"crossref","unstructured":"All of Us Research Program, I. et al. The \u201cAll of Us\u201d Research Program. N. Engl. J. Med. 381, 668\u2013676 (2019).","DOI":"10.1056\/NEJMsr1809937"},{"key":"62789_CR54","unstructured":"All of Us Beta Release Genomic Quality Report (ARCHIVED C2021Q3R6 CDR CT Dataset v5). https:\/\/support.researchallofus.org\/hc\/en-us\/articles\/7002036503700-All-of-Us-Beta-Release-Genomic-Quality-Report-ARCHIVED-C2021Q3R6-CDR-CT-Dataset-v5. Accessed 6 May 2024."},{"key":"62789_CR55","unstructured":"All of Us Genomic Quality Report. https:\/\/support.researchallofus.org\/hc\/en-us\/articles\/4617899955092-All-of-Us-Genomic-Quality-Report. accessed 6 May 2024."},{"key":"62789_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"62789_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"62789_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome. Biol. 17, 122 (2016).","journal-title":"Genome. Biol."},{"key":"62789_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/humu.22932","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu, X., Wu, C., Li, C. & Boerwinkle, E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum. Mutat. 37, 235\u2013241 (2016).","journal-title":"Hum. Mutat."},{"key":"62789_CR60","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41588-023-01342-w","volume":"55","author":"SJ Jurgens","year":"2023","unstructured":"Jurgens, S. J. et al. Adjusting for common variant polygenic scores improves yield in rare variant association analyses. Nat. Genet. 55, 544\u2013548 (2023).","journal-title":"Nat. Genet."},{"key":"62789_CR61","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.xgen.2022.100241","volume":"3","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts. Cell Genom. 3, 100241 (2023).","journal-title":"Cell Genom."},{"key":"62789_CR62","doi-asserted-by":"crossref","unstructured":"Grover, S. P. et al. C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. Blood 141, 2390\u20132401 (2023).","DOI":"10.1182\/blood.2022018849"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62789-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:01:47Z","timestamp":1784584907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62789-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62789"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62789-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of Supplementary Information initially published alongside this article, a footnote in Table S1 describing <i>All of Us<\/i> participant counts was incorrect and is now amended in the Supplementary Information.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8176"}}